Cargando…
Termination of anticoagulation therapy at 45 days after concomitant atrial fibrillation catheter ablation and left atrial appendage occlusion resulting in device-related thrombosis and stroke
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420035/ https://www.ncbi.nlm.nih.gov/pubmed/28491759 http://dx.doi.org/10.1016/j.hrcr.2016.11.008 |
| _version_ | 1783234327903993856 |
|---|---|
| author | Carlson, Steven K Doshi, Rahul N |
| author_facet | Carlson, Steven K Doshi, Rahul N |
| author_sort | Carlson, Steven K |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5420035 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-54200352017-05-10 Termination of anticoagulation therapy at 45 days after concomitant atrial fibrillation catheter ablation and left atrial appendage occlusion resulting in device-related thrombosis and stroke Carlson, Steven K Doshi, Rahul N HeartRhythm Case Rep Janssen Award Recipient Elsevier 2017-01-03 /pmc/articles/PMC5420035/ /pubmed/28491759 http://dx.doi.org/10.1016/j.hrcr.2016.11.008 Text en © 2016 Heart Rhythm Society. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Janssen Award Recipient Carlson, Steven K Doshi, Rahul N Termination of anticoagulation therapy at 45 days after concomitant atrial fibrillation catheter ablation and left atrial appendage occlusion resulting in device-related thrombosis and stroke |
| title | Termination of anticoagulation therapy at 45 days after concomitant atrial fibrillation catheter ablation and left atrial appendage occlusion resulting in device-related thrombosis and stroke |
| title_full | Termination of anticoagulation therapy at 45 days after concomitant atrial fibrillation catheter ablation and left atrial appendage occlusion resulting in device-related thrombosis and stroke |
| title_fullStr | Termination of anticoagulation therapy at 45 days after concomitant atrial fibrillation catheter ablation and left atrial appendage occlusion resulting in device-related thrombosis and stroke |
| title_full_unstemmed | Termination of anticoagulation therapy at 45 days after concomitant atrial fibrillation catheter ablation and left atrial appendage occlusion resulting in device-related thrombosis and stroke |
| title_short | Termination of anticoagulation therapy at 45 days after concomitant atrial fibrillation catheter ablation and left atrial appendage occlusion resulting in device-related thrombosis and stroke |
| title_sort | termination of anticoagulation therapy at 45 days after concomitant atrial fibrillation catheter ablation and left atrial appendage occlusion resulting in device-related thrombosis and stroke |
| topic | Janssen Award Recipient |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420035/ https://www.ncbi.nlm.nih.gov/pubmed/28491759 http://dx.doi.org/10.1016/j.hrcr.2016.11.008 |
| work_keys_str_mv | AT carlsonstevenk terminationofanticoagulationtherapyat45daysafterconcomitantatrialfibrillationcatheterablationandleftatrialappendageocclusionresultingindevicerelatedthrombosisandstroke AT doshirahuln terminationofanticoagulationtherapyat45daysafterconcomitantatrialfibrillationcatheterablationandleftatrialappendageocclusionresultingindevicerelatedthrombosisandstroke |